Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Selectins and neutrophil elastase represent two distinct but functionally linked components of the inflammatory cascade, particularly in the context of leukocyte recruitment and tissue damage. Selectins (E, L, and P) are cell surface glycoproteins that mediate the initial rolling of neutrophils and other leukocytes on the vascular endothelium, which is a prerequisite for firm adhesion and extravasation into inflamed tissues. Once neutrophils reach the site of inflammation, they release neutrophil elastase, a potent serine protease capable of degrading various extracellular matrix components such as elastin and collagen, as well as activating other pro-inflammatory mediators. Therapeutic strategies targeting this axis aim to both prevent the influx of inflammatory cells and mitigate the subsequent proteolytic damage they cause. This dual-pronged approach is primarily investigated for chronic inflammatory conditions of the lung, such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis, where excessive neutrophil activity is a hallmark of disease progression.
Inhibition of selectin-mediated leukocyte rolling and adhesion to the endothelium, combined with the inhibition of neutrophil elastase-mediated extracellular matrix degradation and pro-inflammatory signaling.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Selectins and neutrophil elastase.